WS06-1 Initial results evaluating combinations of the novel CFTR corrector PTI-801, potentiator PTI-808, and amplifier PTI-428 in cystic fibrosis subjects

D. Downey, P. Flume, M. Jain, I. Fajac, C. Schwarz, T. Pressler, S. Van Koningsbruggen-Rietschel, J. Taylor-Cousar, A. Horsley, S. Sutharsan, J. Miller, G. Poirier, J. Jiang, T. Inoue, S. Wilson, P.-S. Lee, G. Gilmartin

Research output: Contribution to journalMeeting abstract

Original languageEnglish
Pages (from-to)S10
Number of pages1
JournalJournal of Cystic Fibrosis
Volume18
Issue numberSuppl 1
DOIs
Publication statusPublished - Jun 2019
Event42nd European Cystic Fibrosis Conference - Liverpool, United Kingdom
Duration: 05 Jun 201908 Jun 2019

Cite this

Downey, D., Flume, P., Jain, M., Fajac, I., Schwarz, C., Pressler, T., Van Koningsbruggen-Rietschel, S., Taylor-Cousar, J., Horsley, A., Sutharsan, S., Miller, J., Poirier, G., Jiang, J., Inoue, T., Wilson, S., Lee, P-S., & Gilmartin, G. (2019). WS06-1 Initial results evaluating combinations of the novel CFTR corrector PTI-801, potentiator PTI-808, and amplifier PTI-428 in cystic fibrosis subjects. Journal of Cystic Fibrosis, 18(Suppl 1), S10. https://doi.org/10.1016/s1569-1993(19)30148-1